OpenVSafe by OpenVAERS
Search V-safe

UQX-30182-44082

3 vaccinations 2 coded responses 35 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
631 / MO
Registered
2021-03-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-26
    Registered in v-safe
  2. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-26
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-16
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-16
    Health check-in — day 0, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · Headache
    Adult check-in
  16. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-14
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-18
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-04-18
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2023-01-13
    Dose 3 — Pfizer-BioNTech
  30. 2023-01-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  31. 2023-01-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  32. 2023-01-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain — Feeling: Fair · Headache, Muscle or body aches
    MedDRA releases: 2024-11
  33. 2023-01-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache
    Adult check-in
  34. 2023-01-20
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2023-01-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2023-02-06
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2023-02-10
    Survey response — day 28, dose 3
    MedDRA: Chest pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  38. 2023-02-10
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  39. 2023-02-13
  40. 2023-02-15
  41. 2023-02-16
    Call successful
    Participant prefers to complete VAERS report online
  42. 2023-02-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  43. 2023-03-02
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-16Pfizer-BioNTech
32023-01-13Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-02-10 Successful
2023-02-16
 Participant prefers to complete VAERS report online

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain · · ✓
SROOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…